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Background: Although an initial IFA-IgG titer greater or equal to 1/64 or 1/128 is considered positive in
presumptive diagnosis, in clinical practice in an endemic setting for rickettsioses in Sri Lanka, some patients with
IFA-IgG titer of 1/128 for either spotted fever group (SFG) or scrub typhus (ST) did not respond to treatment.
Findings: To determine a clinically helpful diagnostic algorithm, IFA-IgG results of serologically confirmed treatment
responders were analyzed in relation to duration of illness at sampling. Of 146 suspected SFG, 3 responders of 25
patients had titers ≤1/128 with < 7 days of illness while all 9 with titers ≥1/256 responded (false negative with 1/
256 cutoff was 12%, false positive was 0%). For illness > 7 days, the false negative and positive rates were 4.3% (3/
59) and 11.3% (6/53). Of 115 suspected ST, false negative and positive rates with ≥1/256 cutoff at <7 days of illness
were 14.2% (2/14) and 0% (0/8) respectively while > 7 days, false negative and positive rates were 2% (1/51) and
0% (0/42).
Conclusions: For clinical decision making, duration of illness at sampling is important in interpreting serology
results in an endemic setting. If sample is obtained ≤7 day of illness, an IgG titer of ≤1/128 requires a follow up
sample in the diagnosis and > 7 days of illness, a single ≥1/256 titer is diagnostic for all ST and 90% of SFG.
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Introduction
Rickettsioses are prevalent in many geographical areas of
the world. Man is an accidental host and when infected,
results in a diverse clinical picture. The presence of an
eschar or a discrete maculo-papular rash helps in the
diagnosis [1]. Most patients have other varying clinical
manifestations which are nonspecific [2]. Presentation as
pyrexia of unknown origin is a fairly common scenario of
rickettsioses in an endemic setting, in addition to extended
morbidity, severe complications and mortality [3].
In most endemic areas the diagnosis of rickettsioses is
mostly on clinical grounds as rickettsial disease confirma-
tory facilities are mostly available in reference laboratories.* Correspondence: ranjanp64@gmail.com
1Department of Medicine, Faculty of Medicine, University of Kelaniya,
Colombo, Sri Lanka
Full list of author information is available at the end of the article
© 2012 Premaratna et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumDespite assay misinterpretations, non-specific cross-reac-
tions, and delayed antibody responses in some patients,
the mainstay of laboratory diagnosis is based on detection
by immuno-fluorescent assays (IFA) of human IgG or
IgM responses against rickettsial antigens [4-6]. Although
PCR based diagnostic methods are available in most refer-
ence laboratories, its availability as a reliable and rapid
clinical diagnostic tool is very limited [6].
As for many other illnesses where the laboratory diag-
nosis is based on serology, a fourfold increase or a
decline in antibody titers is required for confirmation
of the illness. Because the convalescent serum has not
yet been collected, clinical management is based on a
presumptive diagnosis or empirical basis made on
disease-compatible clinical features together with a sin-
gle IFA-IgM titer or an IFA- IgG titer greater than a set
cutoff level for the geographical region [6]. However,
detection of IgM in the diagnosis of acute rickettsioses istral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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antigens [6]. The current presumptive diagnostic titer
for IFA-IgG in a single acute serum sample is set at ≥ 1/
64 or ≥1/128 by different laboratories based on the back-
ground sero-prevalence of rickettsioses in a given geo-
graphical location [6,7].
In Sri Lanka, rickettsioses comprise a significant por-
tion of acute febrile illness and pyrexia of uncertain ori-
gin and it is the 5th most common infectious disease.
Until 2008, the diagnosis of rickettsioses within the
country was based only on clinical features, or inferred
by clinical response to anti-rickettsial antibiotics or the
non-specific Weil Felix test, which has many limitations
for scrub typhus. In June 2008, rickettsial disease diag-
nostics based on IFA was established in collaboration
with CDC Atlanta, Georgia, USA. Since then, it has
become increasingly apparent that many geographic
locations of the island have a high background sero-
prevalence of IgG antibodies against O. tsutsugamushi
the organism responsible for scrub typhus (ST) and
against spotted fever group (SFG) rickettsioses, making
it more difficult to interpret a single IFA-IgG titer in the
diagnosis of acute rickettsioses in patients with acute fe-
brile illness (unpublished data). Furthermore, as most
requests for rickettsial disease diagnostics are done at a
late stage of clinical illness, these factors cause difficul-
ties in interpreting initial IgG titers which are below 128.
Therefore, we felt there was a need for clinically useful
diagnostic algorithms for interpreting IgG titers based
on the duration of clinical illness at presentation of the
patient in different endemic settings.
Objectives
In this study, we aimed to identify a clinically useful
diagnostic algorithm for interpreting IgG titers taking
into account the duration of clinical illness at presenta-
tion when the first serum sample was collected.
Methods
A database was maintained prospectively at the Rickett-
sial Disease Diagnostic and Research Laboratory
(RDDRL), Faculty of Medicine, University of Kelaniya,
Sri Lanka from its inception in June 2008. The data
included in the database consisted of clinical details and
laboratory investigation results which were provided in a
detailed structured request form that should accompany
the appropriate blood or serum samples at the time the
rickettsial diseases diagnostic tests were requested. The
database was updated with the rickettsial diseases IFA-
IgG titres and also with the details of clinical response
with appropriate anti-rickettsial antibiotics. The database
of RDDRL, which contains IgG results for clinical cases
of suspected rickettsioses (potential cases) on admission
based on clinical features and basic investigations wasthen retrospectively analyzed in relation to the known
duration of illness at the time of sampling and whether
the patients responded favorably to anti-rickettsial anti-
biotics such as doxycycline or azithromycin. Out of
which, those who were confirmed having rickettsioses
either by seroconversion on a follow up sample after
2–3 weeks or who had initial very high titres (>1/512)
and responded to anti-rickettsial antibiotics were
selected. Presently we consider rising IFA-IgG titres as
gold standard in the diagnosis of acute rickettsioses as
we do not have PCR based rickettsial disease diagnostics.
Based on CDC recommendations, an initial IFA-IgG
titre of 1/128 is currently used in the presumptive diag-
nosis of acute rickettsioses on acute serum samples
obtained at admission in clinically suspected cases. A
respondant was defined, when the fever subsided within
48–72 hours of initiating anti-rickettsial antibiotics. In
the RDDRL, IFA assays were carried out using rickettsial
antigens grown in culture: Rickettsia conorii (Malish)
and Orientia tsutsugamushi (Karp). Antibodies were
detected using fluorescein conjugated goat anti-human
IgG(γ) or IgM(μ) (KPL, Inc., Gaithersburg, MD, USA).
Ethical clearance to publish these data without revealing
patient personal details of identities was obtained from
the Ethics Review Committee, Faculty of Medicine, Uni-
versity of Kelaniya, Sri Lanka.
Results
Out of 478 samples that had been analyzed for rickett-
sioses by November 2010, the date of collection in rela-
tion to illness and follow up serology was known in 261
(Table 1). Fifty six had been sent on or before the 7th
day of illness with a mean of 5 days, and 205 were sent
after the 7th day with a mean of 19 days. The number
positive at different titers on initial serum sampling,
(reciprocal of last positive endpoint dilution) their
sero-conversion and response to treatment are given in
the table.
Of the 146 suspected SFG infections, only 3 respon-
ders of 25 patients had titers ≤ 1/128 with less than
7 days of illness while all 9 with titers ≥ 1/256
responded (false negative with 1/256 cutoff was 12%,
false positive was 0%). For illness that was greater
than 7 days, the false negative and positive rates at
≥ 1/256 were 5% (3/59) and 11.3% (6/53). For the
115 suspected ST infections false negative and posi-
tive rates with ≥ 1/256 cutoff at less than 7 days of
illness were (2/14) and 0% (0/8) respectively while with
illness greater than 7 days, false negative and positive
rates were 2% (1/51) and 0% (0/42).
Discussion
This study helped us to formulate a clinically useful
diagnostic algorithm considering the duration of
Table 1 Admission IFA-IgG titres confirming SFG and ST in relation to duration of illness
Disease Total Duration of illness when serum was obtained ≤ 7 days
≤1/128 Sero-converted Responded ≥1/256 Sero-converted (High initial titres) Responded
SFG 34 25 3 3 9 7 (2) All (9)
ST 22 14 2 2 8 5 (3) All (8)
Disease Total Duration of illness when serum was obtained > 7 days
≤1/128 Sero-converted Responded ≥1/256 Sero-converted (High initial titres) Responded
SFG 112 59 3 3 53 21 (26) 47
ST 93 51 1 1 42 16 (26) All (42)
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obtained for IgG diagnosis of rickettsioses in an en-
demic setting. There are two groups of serum sam-
ples that require mention about its meaning
concerning their diagnostic values: i. titer ≥ 1/256,
≤ 7days of illness, ii. Titer ≤1/128, > 7 days of illness.
When the sample is obtained > 7 days of illness, a
single ≥ 1/256 titer is diagnostic for all scrub typhus
(ST) infections and 90% of SFG infections. However,
for either SFG or ST, if the sample is obtained ≤ 7
day of illness, an IgG titer of ≤ 1/128 requires a fol-
low up sample in the diagnosis. Most patients who
had a 1/128 or 1/64 titer (the cutoff which is recom-
mended by the CDC in the presumptive diagnosis of
acute rickettsioses) in a sample obtained after the 7th
day of illness had no clinical rickettsioses. Our find-
ings are in keeping with a higher diagnostic cutoff
titers recommended by some commercially available
rapid diagnostic test kits [8].
Furthermore, it is important to identify the species
causing the rickettsioses that are prevalent in a given
geographical location because it is known that some
rickettsial species are known to induce delayed immuno-
logical responses and therefore, a delayed rise in IgM
and IgG titres [6,8,9]. One drawback in our results is
that we are still unaware of the spectrum of SFG and ST
rickettsial organisms causing disease within our geog-
raphy and whether higher titers against autochthonous
SFG or ST antigens might be obtained than with R. con-
orii or Orientia tsutsugamushi Karp. Therefore, it is
recommended that while initial higher IgG titers against
rickettsioses seem to be more accurate in the diagnosis
of acute rickettsioses, further studies are needed in order
to identify the spectrum of rickettsioses in the country.
Consequently, another study to look at concomitant
changes in IFA-IgM titers may help to clarify uncertain-
ties of mixed IFA-IgG titers against SFG, murine typhus,
or ST in the diagnosis of acute rickettsioses in the coun-
try. However, cost is the major drawback in additional
evaluation of IgM titers in the diagnosis of rickettsioses
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